0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Equine Drugs and Supplement Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-13H14346
Home | Market Reports | Pets & Animals| Animal Products & Services| Pet Food & Supplies
Global Equine Drugs and Supplement Market Research Report 2023
BUY CHAPTERS

Global Equine Drugs and Supplement Market Research Report 2025

Code: QYRE-Auto-13H14346
Report
May 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Equine Drugs and Supplement Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Equine Drugs and Supplement Market

Equine Drugs and Supplement Market

The global market for Equine Drugs and Supplement was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Equine Drugs and Supplement, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Equine Drugs and Supplement.
The Equine Drugs and Supplement market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Equine Drugs and Supplement market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Equine Drugs and Supplement manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Equine Drugs and Supplement Market Report

Report Metric Details
Report Name Equine Drugs and Supplement Market
CAGR 5%
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bayer Animal Health, Boehringer Ingelheim, Elanco (Eli Lilly), Merck Animal Health, Merial, Novartis Animal Health, Zoetis
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Equine Drugs and Supplement manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Equine Drugs and Supplement in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Equine Drugs and Supplement Market report?

Ans: The main players in the Equine Drugs and Supplement Market are Bayer Animal Health, Boehringer Ingelheim, Elanco (Eli Lilly), Merck Animal Health, Merial, Novartis Animal Health, Zoetis

What are the Application segmentation covered in the Equine Drugs and Supplement Market report?

Ans: The Applications covered in the Equine Drugs and Supplement Market report are Drugstores, Veterinary Hospitals, Others

What are the Type segmentation covered in the Equine Drugs and Supplement Market report?

Ans: The Types covered in the Equine Drugs and Supplement Market report are Supplements, Pharmaceutical Drugs

Recommended Reports

Animal Health Markets

Pharmaceutical Industry

Disease Treatment Drugs

1 Equine Drugs and Supplement Market Overview
1.1 Product Definition
1.2 Equine Drugs and Supplement by Type
1.2.1 Global Equine Drugs and Supplement Market Value Comparison by Type (2024 VS 2031)
1.2.2 Supplements
1.2.3 Pharmaceutical Drugs
1.3 Equine Drugs and Supplement by Application
1.3.1 Global Equine Drugs and Supplement Market Value by Application (2024 VS 2031)
1.3.2 Drugstores
1.3.3 Veterinary Hospitals
1.3.4 Others
1.4 Global Equine Drugs and Supplement Market Size Estimates and Forecasts
1.4.1 Global Equine Drugs and Supplement Revenue 2020-2031
1.4.2 Global Equine Drugs and Supplement Sales 2020-2031
1.4.3 Global Equine Drugs and Supplement Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Equine Drugs and Supplement Market Competition by Manufacturers
2.1 Global Equine Drugs and Supplement Sales Market Share by Manufacturers (2020-2025)
2.2 Global Equine Drugs and Supplement Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Equine Drugs and Supplement Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Equine Drugs and Supplement, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Equine Drugs and Supplement, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Equine Drugs and Supplement, Product Type & Application
2.7 Global Key Manufacturers of Equine Drugs and Supplement, Date of Enter into This Industry
2.8 Global Equine Drugs and Supplement Market Competitive Situation and Trends
2.8.1 Global Equine Drugs and Supplement Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Equine Drugs and Supplement Players Market Share by Revenue
2.8.3 Global Equine Drugs and Supplement Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Equine Drugs and Supplement Market Scenario by Region
3.1 Global Equine Drugs and Supplement Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Equine Drugs and Supplement Sales by Region: 2020-2031
3.2.1 Global Equine Drugs and Supplement Sales by Region: 2020-2025
3.2.2 Global Equine Drugs and Supplement Sales by Region: 2026-2031
3.3 Global Equine Drugs and Supplement Revenue by Region: 2020-2031
3.3.1 Global Equine Drugs and Supplement Revenue by Region: 2020-2025
3.3.2 Global Equine Drugs and Supplement Revenue by Region: 2026-2031
3.4 North America Equine Drugs and Supplement Market Facts & Figures by Country
3.4.1 North America Equine Drugs and Supplement Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Equine Drugs and Supplement Sales by Country (2020-2031)
3.4.3 North America Equine Drugs and Supplement Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Equine Drugs and Supplement Market Facts & Figures by Country
3.5.1 Europe Equine Drugs and Supplement Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Equine Drugs and Supplement Sales by Country (2020-2031)
3.5.3 Europe Equine Drugs and Supplement Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Equine Drugs and Supplement Market Facts & Figures by Region
3.6.1 Asia Pacific Equine Drugs and Supplement Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Equine Drugs and Supplement Sales by Region (2020-2031)
3.6.3 Asia Pacific Equine Drugs and Supplement Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Equine Drugs and Supplement Market Facts & Figures by Country
3.7.1 Latin America Equine Drugs and Supplement Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Equine Drugs and Supplement Sales by Country (2020-2031)
3.7.3 Latin America Equine Drugs and Supplement Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Equine Drugs and Supplement Market Facts & Figures by Country
3.8.1 Middle East and Africa Equine Drugs and Supplement Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Equine Drugs and Supplement Sales by Country (2020-2031)
3.8.3 Middle East and Africa Equine Drugs and Supplement Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Equine Drugs and Supplement Sales by Type (2020-2031)
4.1.1 Global Equine Drugs and Supplement Sales by Type (2020-2025)
4.1.2 Global Equine Drugs and Supplement Sales by Type (2026-2031)
4.1.3 Global Equine Drugs and Supplement Sales Market Share by Type (2020-2031)
4.2 Global Equine Drugs and Supplement Revenue by Type (2020-2031)
4.2.1 Global Equine Drugs and Supplement Revenue by Type (2020-2025)
4.2.2 Global Equine Drugs and Supplement Revenue by Type (2026-2031)
4.2.3 Global Equine Drugs and Supplement Revenue Market Share by Type (2020-2031)
4.3 Global Equine Drugs and Supplement Price by Type (2020-2031)
5 Segment by Application
5.1 Global Equine Drugs and Supplement Sales by Application (2020-2031)
5.1.1 Global Equine Drugs and Supplement Sales by Application (2020-2025)
5.1.2 Global Equine Drugs and Supplement Sales by Application (2026-2031)
5.1.3 Global Equine Drugs and Supplement Sales Market Share by Application (2020-2031)
5.2 Global Equine Drugs and Supplement Revenue by Application (2020-2031)
5.2.1 Global Equine Drugs and Supplement Revenue by Application (2020-2025)
5.2.2 Global Equine Drugs and Supplement Revenue by Application (2026-2031)
5.2.3 Global Equine Drugs and Supplement Revenue Market Share by Application (2020-2031)
5.3 Global Equine Drugs and Supplement Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bayer Animal Health
6.1.1 Bayer Animal Health Company Information
6.1.2 Bayer Animal Health Description and Business Overview
6.1.3 Bayer Animal Health Equine Drugs and Supplement Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bayer Animal Health Equine Drugs and Supplement Product Portfolio
6.1.5 Bayer Animal Health Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Company Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Equine Drugs and Supplement Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Boehringer Ingelheim Equine Drugs and Supplement Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 Elanco (Eli Lilly)
6.3.1 Elanco (Eli Lilly) Company Information
6.3.2 Elanco (Eli Lilly) Description and Business Overview
6.3.3 Elanco (Eli Lilly) Equine Drugs and Supplement Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Elanco (Eli Lilly) Equine Drugs and Supplement Product Portfolio
6.3.5 Elanco (Eli Lilly) Recent Developments/Updates
6.4 Merck Animal Health
6.4.1 Merck Animal Health Company Information
6.4.2 Merck Animal Health Description and Business Overview
6.4.3 Merck Animal Health Equine Drugs and Supplement Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Merck Animal Health Equine Drugs and Supplement Product Portfolio
6.4.5 Merck Animal Health Recent Developments/Updates
6.5 Merial
6.5.1 Merial Company Information
6.5.2 Merial Description and Business Overview
6.5.3 Merial Equine Drugs and Supplement Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Merial Equine Drugs and Supplement Product Portfolio
6.5.5 Merial Recent Developments/Updates
6.6 Novartis Animal Health
6.6.1 Novartis Animal Health Company Information
6.6.2 Novartis Animal Health Description and Business Overview
6.6.3 Novartis Animal Health Equine Drugs and Supplement Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Novartis Animal Health Equine Drugs and Supplement Product Portfolio
6.6.5 Novartis Animal Health Recent Developments/Updates
6.7 Zoetis
6.7.1 Zoetis Company Information
6.7.2 Zoetis Description and Business Overview
6.7.3 Zoetis Equine Drugs and Supplement Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Zoetis Equine Drugs and Supplement Product Portfolio
6.7.5 Zoetis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Equine Drugs and Supplement Industry Chain Analysis
7.2 Equine Drugs and Supplement Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Equine Drugs and Supplement Production Mode & Process Analysis
7.4 Equine Drugs and Supplement Sales and Marketing
7.4.1 Equine Drugs and Supplement Sales Channels
7.4.2 Equine Drugs and Supplement Distributors
7.5 Equine Drugs and Supplement Customer Analysis
8 Equine Drugs and Supplement Market Dynamics
8.1 Equine Drugs and Supplement Industry Trends
8.2 Equine Drugs and Supplement Market Drivers
8.3 Equine Drugs and Supplement Market Challenges
8.4 Equine Drugs and Supplement Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Equine Drugs and Supplement Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Equine Drugs and Supplement Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Equine Drugs and Supplement Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Equine Drugs and Supplement Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Equine Drugs and Supplement Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Equine Drugs and Supplement Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Equine Drugs and Supplement Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Equine Drugs and Supplement Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Equine Drugs and Supplement, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Equine Drugs and Supplement, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Equine Drugs and Supplement, Product Type & Application
 Table 12. Global Key Manufacturers of Equine Drugs and Supplement, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Equine Drugs and Supplement by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Equine Drugs and Supplement as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Equine Drugs and Supplement Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Equine Drugs and Supplement Sales by Region (2020-2025) & (K Units)
 Table 18. Global Equine Drugs and Supplement Sales Market Share by Region (2020-2025)
 Table 19. Global Equine Drugs and Supplement Sales by Region (2026-2031) & (K Units)
 Table 20. Global Equine Drugs and Supplement Sales Market Share by Region (2026-2031)
 Table 21. Global Equine Drugs and Supplement Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Equine Drugs and Supplement Revenue Market Share by Region (2020-2025)
 Table 23. Global Equine Drugs and Supplement Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Equine Drugs and Supplement Revenue Market Share by Region (2026-2031)
 Table 25. North America Equine Drugs and Supplement Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Equine Drugs and Supplement Sales by Country (2020-2025) & (K Units)
 Table 27. North America Equine Drugs and Supplement Sales by Country (2026-2031) & (K Units)
 Table 28. North America Equine Drugs and Supplement Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Equine Drugs and Supplement Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Equine Drugs and Supplement Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Equine Drugs and Supplement Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Equine Drugs and Supplement Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Equine Drugs and Supplement Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Equine Drugs and Supplement Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Equine Drugs and Supplement Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Equine Drugs and Supplement Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Equine Drugs and Supplement Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Equine Drugs and Supplement Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Equine Drugs and Supplement Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Equine Drugs and Supplement Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Equine Drugs and Supplement Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Equine Drugs and Supplement Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Equine Drugs and Supplement Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Equine Drugs and Supplement Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Equine Drugs and Supplement Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Equine Drugs and Supplement Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Equine Drugs and Supplement Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Equine Drugs and Supplement Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Equine Drugs and Supplement Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Equine Drugs and Supplement Sales (K Units) by Type (2020-2025)
 Table 51. Global Equine Drugs and Supplement Sales (K Units) by Type (2026-2031)
 Table 52. Global Equine Drugs and Supplement Sales Market Share by Type (2020-2025)
 Table 53. Global Equine Drugs and Supplement Sales Market Share by Type (2026-2031)
 Table 54. Global Equine Drugs and Supplement Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Equine Drugs and Supplement Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Equine Drugs and Supplement Revenue Market Share by Type (2020-2025)
 Table 57. Global Equine Drugs and Supplement Revenue Market Share by Type (2026-2031)
 Table 58. Global Equine Drugs and Supplement Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Equine Drugs and Supplement Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Equine Drugs and Supplement Sales (K Units) by Application (2020-2025)
 Table 61. Global Equine Drugs and Supplement Sales (K Units) by Application (2026-2031)
 Table 62. Global Equine Drugs and Supplement Sales Market Share by Application (2020-2025)
 Table 63. Global Equine Drugs and Supplement Sales Market Share by Application (2026-2031)
 Table 64. Global Equine Drugs and Supplement Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Equine Drugs and Supplement Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Equine Drugs and Supplement Revenue Market Share by Application (2020-2025)
 Table 67. Global Equine Drugs and Supplement Revenue Market Share by Application (2026-2031)
 Table 68. Global Equine Drugs and Supplement Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Equine Drugs and Supplement Price (US$/Unit) by Application (2026-2031)
 Table 70. Bayer Animal Health Company Information
 Table 71. Bayer Animal Health Description and Business Overview
 Table 72. Bayer Animal Health Equine Drugs and Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Bayer Animal Health Equine Drugs and Supplement Product
 Table 74. Bayer Animal Health Recent Developments/Updates
 Table 75. Boehringer Ingelheim Company Information
 Table 76. Boehringer Ingelheim Description and Business Overview
 Table 77. Boehringer Ingelheim Equine Drugs and Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Boehringer Ingelheim Equine Drugs and Supplement Product
 Table 79. Boehringer Ingelheim Recent Developments/Updates
 Table 80. Elanco (Eli Lilly) Company Information
 Table 81. Elanco (Eli Lilly) Description and Business Overview
 Table 82. Elanco (Eli Lilly) Equine Drugs and Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Elanco (Eli Lilly) Equine Drugs and Supplement Product
 Table 84. Elanco (Eli Lilly) Recent Developments/Updates
 Table 85. Merck Animal Health Company Information
 Table 86. Merck Animal Health Description and Business Overview
 Table 87. Merck Animal Health Equine Drugs and Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Merck Animal Health Equine Drugs and Supplement Product
 Table 89. Merck Animal Health Recent Developments/Updates
 Table 90. Merial Company Information
 Table 91. Merial Description and Business Overview
 Table 92. Merial Equine Drugs and Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Merial Equine Drugs and Supplement Product
 Table 94. Merial Recent Developments/Updates
 Table 95. Novartis Animal Health Company Information
 Table 96. Novartis Animal Health Description and Business Overview
 Table 97. Novartis Animal Health Equine Drugs and Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Novartis Animal Health Equine Drugs and Supplement Product
 Table 99. Novartis Animal Health Recent Developments/Updates
 Table 100. Zoetis Company Information
 Table 101. Zoetis Description and Business Overview
 Table 102. Zoetis Equine Drugs and Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Zoetis Equine Drugs and Supplement Product
 Table 104. Zoetis Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Equine Drugs and Supplement Distributors List
 Table 108. Equine Drugs and Supplement Customers List
 Table 109. Equine Drugs and Supplement Market Trends
 Table 110. Equine Drugs and Supplement Market Drivers
 Table 111. Equine Drugs and Supplement Market Challenges
 Table 112. Equine Drugs and Supplement Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Equine Drugs and Supplement
 Figure 2. Global Equine Drugs and Supplement Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Equine Drugs and Supplement Market Share by Type: 2024 & 2031
 Figure 4. Supplements Product Picture
 Figure 5. Pharmaceutical Drugs Product Picture
 Figure 6. Global Equine Drugs and Supplement Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Equine Drugs and Supplement Market Share by Application: 2024 & 2031
 Figure 8. Drugstores
 Figure 9. Veterinary Hospitals
 Figure 10. Others
 Figure 11. Global Equine Drugs and Supplement Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Equine Drugs and Supplement Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Equine Drugs and Supplement Sales (2020-2031) & (K Units)
 Figure 14. Global Equine Drugs and Supplement Average Price (US$/Unit) & (2020-2031)
 Figure 15. Equine Drugs and Supplement Report Years Considered
 Figure 16. Equine Drugs and Supplement Sales Share by Manufacturers in 2024
 Figure 17. Global Equine Drugs and Supplement Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Equine Drugs and Supplement Players: Market Share by Revenue in Equine Drugs and Supplement in 2024
 Figure 19. Equine Drugs and Supplement Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Equine Drugs and Supplement Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Equine Drugs and Supplement Sales Market Share by Country (2020-2031)
 Figure 22. North America Equine Drugs and Supplement Revenue Market Share by Country (2020-2031)
 Figure 23. United States Equine Drugs and Supplement Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Equine Drugs and Supplement Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Equine Drugs and Supplement Sales Market Share by Country (2020-2031)
 Figure 26. Europe Equine Drugs and Supplement Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Equine Drugs and Supplement Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Equine Drugs and Supplement Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Equine Drugs and Supplement Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Equine Drugs and Supplement Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Equine Drugs and Supplement Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Equine Drugs and Supplement Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Equine Drugs and Supplement Revenue Market Share by Region (2020-2031)
 Figure 34. China Equine Drugs and Supplement Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Equine Drugs and Supplement Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Equine Drugs and Supplement Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Equine Drugs and Supplement Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Equine Drugs and Supplement Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Equine Drugs and Supplement Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Equine Drugs and Supplement Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Equine Drugs and Supplement Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Equine Drugs and Supplement Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Equine Drugs and Supplement Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Equine Drugs and Supplement Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Equine Drugs and Supplement Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Equine Drugs and Supplement Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Equine Drugs and Supplement Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Equine Drugs and Supplement Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Equine Drugs and Supplement Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Equine Drugs and Supplement Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Equine Drugs and Supplement by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Equine Drugs and Supplement by Type (2020-2031)
 Figure 53. Global Equine Drugs and Supplement Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Equine Drugs and Supplement by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Equine Drugs and Supplement by Application (2020-2031)
 Figure 56. Global Equine Drugs and Supplement Price (US$/Unit) by Application (2020-2031)
 Figure 57. Equine Drugs and Supplement Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS